Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifonazole versus placebo after urea nail ablation for onychomycosis
2008-003215-13Phase 3Completed
- Sponsor
- Bayer Consumer Health
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in onychomycosis comparing Bifonazole follow-up treatment with Placebo follow-up treatment (2 arms). Primary endpoint: Overall cure rate. Started Sep 2008; status: completed.
02
Drugs
bifonazole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2008-003215-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003215-13.